Symbol
CTSO on Nasdaq
Investment type
Equity / Common Stock, par value $0.001 per share
Latest Disclosed Ownership
3.76M shares
Security Ownership
5.7%

Avenue Capital Management II, L.P. ownership in Cytosorbents Corp Common Stock, par value $0.001 per share (CTSO)

2025-05-28 - Avenue Capital Management II, L.P. has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 3.76M shares of Cytosorbents Corp Common Stock, par value $0.001 per share (CTSO). This represents 5.7% percent ownership of the company.